Acusphere, Inc. (ACUS)

Market Cap	5.00
Revenue (ttm)	2.68M
Net Income (ttm)	-69.42M
Shares Out	4.95M
EPS (ttm)	-14.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125
Average Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	-0.20
RSI	29.99
Earnings Date	n/a

About Acusphere

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUS

Financial Performance

In 2008, Acusphere's revenue was $2.68 million, an increase of 0.64% compared to the previous year's $2.67 million. Losses were -$69.42 million, 24.0% more than in 2007.